OncoLink Cancer Treatment and Resources
OncoLink Cancer Treatment and Resources
Link to OncoLink

CIS "carcinoma in situ" and CIN Cervical Intraepithelial Neoplasia explained

Christina S. Chu
Ultima Vez Modificado: 3 de febrero del 2002

Question

Dear OncoLink "Ask The Experts,"

I have just been diagnosed with carcinoma in situ. My gynecologist has Set up an appointment with a gynecological oncologist for tomorrow. They are telling me that it is stage CIN III. What does that mean? Does it mean my cancer is in stage III?  


Answer

Christina S. Chu, MD Assistant Professor of the Division of Gynecologic Oncology at the University of Pennsylvania Health System, responds:

The classification of cervical cancer can be confusing because there are many different systems. The CIN system stands for Cervical Intraepithelial Neoplasia. CIN refers to lesions that do not invade the tissue of the cervix. In other words, the abnormal cells merely sit on the surface of the cervix. Sometimes these abnormal cells are described to patients as "precancerous". CIN lesions are graded as I (mild), II (moderate), or III (severe). The term "carcinoma in situ" or CIS can be used with CIN III. Both mean a precancerous lesion that has not invaded into the substance of the cervix.

Staging is a term that describes how far an invasive cervical cancer has spread. Stage I cervical cancer has invaded into the cervix, but has not extended outside of the cervix. Stage II cancer has spread to the upper vagina, or into the tissue to the sides of the cervix (the parametria). Stage III cancer has spread all the way to the sidewall of the pelvis or has caused blockage of a kidney. Stage IV disease means that cancer has extended to other organs such as the bowel or bladder.

In response to your question, CIN and staging are different. If your doctor told you that you have a CIN III lesion, this does not mean that you have a stage III cancer.


OncoLink I wish u knew...

As an oncologist, Dr. Giantonio provides care for many patients at the end of life, which he describes as a privilege and rewarding. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS